Trials / Unknown
UnknownNCT01988545
GLP-1's Effect on Cardiac Parameters and Mesenteric Blood Flow
GLP-1's Influence on Intestinal Blood Flow
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 8 (estimated)
- Sponsor
- Zealand University Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
to investigate the effect of the human incretin hormone GLP-1 on mesenteric blood flow and cardiac parameters
Detailed description
to investigate the effect of the human incretin hormone GLP-1 on mesenteric blood flow and cardiac parameters, in healthy subjects, 4 arms, task force monitor
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | 1,5 nmol/kg,GLP-1 sc injection | |
| OTHER | 1,5 nmol/kg GLP-1 9-36amide, sc injection | |
| OTHER | Exendin-4 ;10 ug,sc injection | |
| OTHER | saline |
Timeline
- Start date
- 2013-11-01
- Primary completion
- 2014-06-01
- Completion
- 2014-12-01
- First posted
- 2013-11-20
- Last updated
- 2013-11-20
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT01988545. Inclusion in this directory is not an endorsement.